GGrantIndex
← Leaderboards

Peter Leon Collins

Niaid Extramural Activities

Google Scholar ↗PubMed ↗ORCID ↗
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

—

By mechanism

—

Top collaborators

No co-investigators on record.

Most similar at Niaid Extramural Activities

Same institution · by research overlap

Others in their field

Top investigators on “Virus”

Research focus

VirusViralAttenuatedVaccinesGenesProteinsRespiratory Syncytial VirusImmunogenicityAttenuationChildhoodGenomeVaccine DevelopmentBaseReportingAntigensGeneticInfectionMutationResponseVaccine CandidatePathogenImmune ResponseImmunogenicClinical Trials

Grant awards (72)

Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,587,976
ZIA · FY2019 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$1,544,121
ZIA · FY2019 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,332,368
ZIA · FY2019 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$464,780
ZIA · FY2019 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,553,196
ZIA · FY2018 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$1,330,999
ZIA · FY2018 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,330,999
ZIA · FY2018 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$295,777
ZIA · FY2018 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$2,313,167
ZIA · FY2017 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,484,945
ZIA · FY2017 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$1,460,645
ZIA · FY2017 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$929,501
ZIA · FY2017 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$4,039,585
ZIA · FY2016 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,435,433
ZIA · FY2016 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,207,417
ZIA · FY2016 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$580,583
ZIA · FY2016 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$1,592,871
ZIA · FY2015 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,520,063
ZIA · FY2015 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,507,995
ZIA · FY2015 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$469,435
ZIA · FY2015 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$2,910,308
ZIA · FY2014 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$1,305,947
ZIA · FY2014 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,261,924
ZIA · FY2014 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,072,901
ZIA · FY2014 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$4,832,360
ZIA · FY2013 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,916,770
ZIA · FY2013 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$671,277
ZIA · FY2013 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$338,254
ZIA · FY2013 · AI · contact PI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses$2,014,197
ZIA · FY2012 · AI · contact PI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses$1,623,430
ZIA · FY2012 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$433,566
ZIA · FY2012 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$421,458
ZIA · FY2012 · AI · contact PI
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines$2,747,716
ZIA · FY2011 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$1,661,610
ZIA · FY2011 · AI · contact PI
Human Respiratory Syncytial Virus Biology And Vaccine Development$1,272,696
ZIA · FY2011 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$304,365
ZIA · FY2011 · AI · contact PI
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines$1,965,364
ZIA · FY2010 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$1,924,593
ZIA · FY2010 · AI · contact PI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses$1,496,654
ZIA · FY2010 · AI · contact PI
Human Respiratory Syncytial Virus Biology And Vaccine Development$1,290,643
ZIA · FY2010 · AI · contact PI
Metapneumovirus Biology and Vaccine Development$430,214
ZIA · FY2010 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$1,425,149
ZIA · FY2009 · AI · contact PI
Human Respiratory Syncytial Virus Biology And Vaccine Development$1,364,152
ZIA · FY2009 · AI · contact PI
Metapneumovirus Biology and Vaccine Development$545,662
ZIA · FY2009 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$2,034,822
Z01 · FY2008 · AI · contact PI
Metapneumovirus Biology and Vaccine Development$1,008,596
Z01 · FY2008 · AI · contact PI
Human Respiratory Syncytial Virus Biology And Vaccine Development$847,282
Z01 · FY2008 · AI · contact PI
Human Respiratory Syncytial Virus Biology And Vaccine Development$10,136,908
Z01 · FY2007 · AI · contact PI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses$1,962,239
Z01 · FY2007 · AI · contact PI
Metapneumovirus Biology and Vaccine Development$695,904
Z01 · FY2007 · AI · contact PI
Metapneumovirus Biology and Vaccine Development$0
Z01 · FY2006 · AI · contact PI
1 Z01 AI000938-03 RV Paramyxoviruses as Vaccine Vectors$0
Z01 · FY2006 · AI · contact PI
Metapneumovirus Biology and Vaccine Development$0
Z01 · FY2005 · AI
Paramyxovirus Vaccine Vectors For Pathogenic Viruses$0
Z01 · FY2005 · AI
Human Respiratory Syncytial Virus Biology And Vaccine De$0
Z01 · FY2005 · AI
Pneumovirus Biology And Vaccine Development$0
Z01 · FY2005 · AI
Pneumovirus Biology And Vaccine Development$0
Z01 · FY2004 · AI
Paramyxoviruse Vaccine Vectors Against Pathogenic Virus$0
Z01 · FY2004 · AI
In Vitro Models of Paramyxovirus Infection$0
Z01 · FY2004 · AI
Metapneumovirus Biology and Vaccine Development$0
Z01 · FY2004 · AI
Pneumovirus Biology And Vaccine Development$0
Z01 · FY2003 · AI
Roles of Pneumovirus Proteins in Virus Replication, Path$0
Z01 · FY2003 · AI
Pneumovirus Genetics$0
Z01 · FY2003 · AI
Respiratory Syncytial Virus Biology And Vaccine Developm$0
Z01 · FY2002 · AI
Functions Of The Proteins Of Human Respiratory Syncytial$0
Z01 · FY2002 · AI
Structural Analysis Of The Genome Of Respiratory Syncyti$0
Z01 · FY2002 · AI
Respiratory Syncytial Virus Biology: Vaccine Development$0
Z01 · FY2001 · AI
Functions of Proteins of Respiratory Syncytial Virus$0
Z01 · FY2001 · AI
Structural Analysis:Genome/Respiratory Syncytial Virus$0
Z01 · FY2001 · AI
REPLICATION,VIRULENCE &IMMUNOGENICITY IN RECOMBINANT RESPIRATORY SYNCYTIAL VIRU$0
Z01 · FY2000 · AI
FUNCTIONS OF THE PROTEINS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS$0
Z01 · FY2000 · AI
STRUCTURAL ANALYSIS OF THE GENOME OF RESPIRATORY SYNCYTIAL VIRUS$0
Z01 · FY2000 · AI